Progyny Inc (PGNY)

Return on equity (ROE)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Net income (ttm) US$ in thousands 54,336 57,274 62,751 61,257 62,037 51,975 49,288 43,065 30,358 42,030 45,615 55,574 65,769 89,761 77,787 57,996 46,459 2,987 -10,045
Total stockholders’ equity US$ in thousands 422,062 434,876 456,193 571,604 553,429 515,393 469,499 424,401 376,968 346,856 311,024 279,619 251,822 224,113 204,541 184,618 166,947 125,886 118,710
ROE 12.87% 13.17% 13.76% 10.72% 11.21% 10.08% 10.50% 10.15% 8.05% 12.12% 14.67% 19.87% 26.12% 40.05% 38.03% 31.41% 27.83% 2.37% -8.46%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $54,336K ÷ $422,062K
= 12.87%

Over the past few years, Progyny Inc's return on equity (ROE) has exhibited some fluctuations. The ROE was negative at -8.46% as of June 30, 2020, indicating a period of unprofitability. However, the company managed to turn this around and achieve positive ROE figures in subsequent quarters.

From September 30, 2020, to June 30, 2021, Progyny Inc saw a consistent improvement in its ROE, with figures increasing steadily from 2.37% to 38.03%. This significant growth indicates that the company was effectively utilizing its equity to generate returns for its shareholders during this period.

Following the peak ROE of 40.05% on September 30, 2021, there was a slight decline in the metric, dropping to 8.05% by December 31, 2022. This decline may suggest challenges or changes in the company's operations or financial performance during that period.

Subsequently, there was a rebound in Progyny Inc's ROE, reaching 13.76% by June 30, 2024, after which the metric stayed relatively stable around the 13% mark for the next few quarters, closing at 12.87% as of December 31, 2024.

Overall, while Progyny Inc experienced fluctuations in its ROE over the analyzed periods, the company demonstrated the ability to improve and maintain healthy returns for its equity holders, with the ROE showing an upward trend in the long term.


Peer comparison

Dec 31, 2024